Near Death Experience (NDE) and Migraine

Migraine Clinical Trial

Official title:

Near Death Experience (NDE) and Migraine

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02854930
• Other study ID #: 2014-47
• Status: Not yet recruiting
• Phase: N/A
• First received: August 1, 2016
• Last updated: August 3, 2016
• Start date: January 2017
• Est. completion date: March 2018

Study information

• Verified date: August 2016
• Source: Assistance Publique Hopitaux De Marseille
• Contact: Anne Donnet
• Phone: 0491382747
• Email: drci[@]ap-hm.fr
• Is FDA regulated: No
• Health authority: France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
• Study type: Observational

Clinical Trial Summary

Migraine is a common disabling primary headache disorder. Epidemiological studies have documented its high prevalence and high socio-economic and personal impacts. Migraine affects more than 20% of the French population. However, the physiopathology of migraine is always partially known. Cortical spreading depression (CSD) is the widely accepted as the electrophysiologic substrate of migraine aura. CSD is a slowly propagating wave of transient neuronal and glial depolarization. The near death experience (NDE) is a rare, but well known phenomenon. NDE are profound psychic experiences commonly occuring in life-threatening conditions. Among the neurological hypotheses, epilepsy, temporal lobe disorders , REM-sleep intrusion have been discussed. However, the role of DCE has never been discussed. The goals of this study are : to see if there is an epidemiological link between NDE and migraine/ to specify if NDE was followed by a migrainous headache.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: March 2018
• Est. primary completion date: January 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Subject who experienced an NDE defined by the occurrence, when the subject is in a state of clinical death or a particular state of consciousness of a following event: body output experience, disembodiment, for a tunnel and / or light;

• Topic recorded in the EMI database (Dr. Postel, National Center for Education, Research and Information on the conscience;

• Topic agreeing to participate in the study.

Exclusion Criteria:

• Patient mental condition or disorder or psychiatric history or any other factor limiting the ability to participate in an informed manner and compliant to the study;

• Other than obtained Participation Agreement.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Death
• Migraine
• Migraine Disorders
• Near Death Experience

Intervention

Other:
• questioning

Locations

Country	Name	City	State
France	Assistance Publique Hôpitaux de Marseille Hôpital de la Timone	Marseille

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life		one day	No